Joseph P Hagan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph P Hagan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph P Hagan. Joseph P Hagan is Chief Business Officer in Orexigen Therapeutics, Inc. ($OREX) and Sr. VP, Corporate Development in Orexigen Therapeutics, Inc. ($OREX) and Chief Operating Officer in Regulus Therapeutics Inc. ($RGLS) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN).
Latest Insider Trading Transactions of Joseph P Hagan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, OREX, RGLS, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 0.93 | 30,000 | 27,954 | 30,000 | |
| Jun 14 2021 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Grant | A | 0.00 | 15,000 | 0 | 22,500 | 7.5 K to 22.5 K (+200.00 %) |
| Apr 16 2021 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | C | 0.00 | 7,585 | 0 | 0 | |
| Apr 16 2021 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Buy | C | 0.00 | 75,850 | 0 | 320,478 | 244.6 K to 320.5 K (+31.01 %) |
| Feb 17 2021 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 1.72 | 4,144 | 7,128 | 485,756 | 489.9 K to 485.8 K (-0.85 %) |
| Dec 07 2020 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.75 | 29,760 | 22,213 | 29,760 | |
| Dec 07 2020 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Grant | A | 0.63 | 39,680 | 25,002 | 225,674 | 186 K to 225.7 K (+21.33 %) |
| Nov 18 2020 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.52 | 6,094 | 3,176 | 215,994 | 222.1 K to 216 K (-2.74 %) |
| Aug 17 2020 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.60 | 4,245 | 2,568 | 222,088 | 226.3 K to 222.1 K (-1.88 %) |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| May 18 2020 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.63 | 4,426 | 2,774 | 226,333 | 230.8 K to 226.3 K (-1.92 %) |
| Jan 24 2020 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 1.31 | 900,000 | 1,179,000 | 900,000 | |
| Dec 26 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.67 | 75,850 | 50,516 | 75,850 | |
| Dec 26 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.00 | 7,585 | 0 | 7,585 | |
| Nov 15 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.64 | 5,838 | 3,736 | 243,428 | 249.3 K to 243.4 K (-2.34 %) |
| Oct 15 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.64 | 1,000,000 | 640,000 | 1,000,000 | |
| Oct 15 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.64 | 1,000,000 | 640,000 | 1,000,000 | |
| Oct 02 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.68 | 8,743 | 5,969 | 249,266 | 258 K to 249.3 K (-3.39 %) |
| Aug 16 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.55 | 4,375 | 2,409 | 258,009 | 262.4 K to 258 K (-1.67 %) |
| Aug 16 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.55 | 4,375 | 2,409 | 258,009 | 262.4 K to 258 K (-1.67 %) |
| Jul 18 2019 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 2.34 | 1,500 | 3,510 | 1,500 | |
| Jul 02 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 1.31 | 5,783 | 7,584 | 262,384 | 268.2 K to 262.4 K (-2.16 %) |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.95 | 10,000 | 9,500 | 10,000 | |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 1.22 | 39,352 | 47,966 | 268,167 | 307.5 K to 268.2 K (-12.80 %) |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Grant | A | 0.00 | 188,385 | 0 | 307,519 | 119.1 K to 307.5 K (+158.13 %) |
| May 08 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | P | 1.08 | 33,194 | 35,850 | 33,194 | |
| May 08 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Buy | P | 1.08 | 33,194 | 35,850 | 64,542 | 31.3 K to 64.5 K (+105.89 %) |
| Apr 03 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Sell | S | 0.98 | 5,842 | 5,731 | 31,348 | 37.2 K to 31.3 K (-15.71 %) |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.95 | 65,000 | 61,750 | 65,000 | |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Grant | A | 0.95 | 65,000 | 61,750 | 84,148 | 19.1 K to 84.1 K (+339.46 %) |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.95 | 65,000 | 61,750 | 65,000 | |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Grant | A | 0.95 | 65,000 | 61,750 | 84,148 | 19.1 K to 84.1 K (+339.46 %) |
| Jun 01 2018 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 4.24 | 25,000 | 106,000 | 25,000 | |
| May 21 2018 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.71 | 725,000 | 514,750 | 725,000 | |
| Mar 02 2018 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 0.53 | 30,000 | 15,900 | 30,000 | |
| Jan 05 2018 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 1.24 | 1,000,000 | 1,240,000 | 1,000,000 | |
| Jul 25 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Buy | P | 0.91 | 219,780 | 200,000 | 241,297 | 21.5 K to 241.3 K (+1,021.42 %) |
| May 08 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 1.70 | 750,000 | 1,275,000 | 750,000 | |
| Feb 23 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 1.20 | 160,000 | 192,000 | 160,000 | |
| Feb 01 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 5.77 | 30,000 | 173,100 | 30,000 | |
| Nov 04 2016 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 0.58 | 20,000 | 11,500 | 20,000 | |
| Oct 07 2016 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 3.52 | 59,625 | 209,880 | 59,625 | |
| Mar 07 2016 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Buy | P | 7.19 | 10,000 | 71,900 | 10,000 | 0 to 10 K |
| Jan 06 2016 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 8.57 | 420,000 | 3,599,400 | 420,000 | |
| May 27 2015 | ZSAN | Zosano Pharma Corp | Hagan Joseph P | Director | Option Exercise | A | 9.29 | 28,000 | 260,120 | 28,000 | |
| Feb 05 2015 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 5.34 | 202,650 | 1,082,151 | 202,650 | |
| Sep 15 2014 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Buy | P | 4.69 | 5,000 | 23,450 | 13,026 | 8 K to 13 K (+62.30 %) |
| Feb 11 2014 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 6.30 | 225,000 | 1,417,500 | 225,000 | |
| Feb 11 2014 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Grant | A | 5.34 | 3,980 | 21,253 | 3,980 | 0 to 4 K |
| Aug 02 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 12,000 | 19,920 | 764,000 | |
| Aug 02 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 7.80 | 12,000 | 93,600 | 0 | 12 K to 0 (-100.00 %) |
| Aug 02 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 12,000 | 19,920 | 12,000 | 0 to 12 K |
| Jul 29 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 10,000 | 16,600 | 776,000 | |
| Jul 29 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 7.40 | 10,000 | 74,000 | 0 | 10 K to 0 (-100.00 %) |
| Jul 29 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 10,000 | 16,600 | 10,000 | 0 to 10 K |
| May 30 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 28,000 | 46,480 | 786,000 | |
| May 30 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 7.00 | 28,000 | 196,000 | 0 | 28 K to 0 (-100.00 %) |
| May 30 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 28,000 | 46,480 | 28,000 | 0 to 28 K |
| Feb 19 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 5.69 | 310,000 | 1,763,900 | 310,000 | |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 30,000 | 49,800 | 814,000 | |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 6.90 | 10,000 | 69,000 | 0 | 10 K to 0 (-100.00 %) |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 6.70 | 20,000 | 134,000 | 10,000 | 30 K to 10 K (-66.67 %) |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 30,000 | 49,800 | 30,000 | 0 to 30 K |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 12,000 | 19,920 | 844,000 | |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 26,000 | 43,160 | 856,000 | |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 70,000 | 116,200 | 882,000 | |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 6.30 | 12,000 | 75,600 | 0 | 12 K to 0 (-100.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 12,000 | 19,920 | 12,000 | 0 to 12 K |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 5.90 | 26,000 | 153,400 | 0 | 26 K to 0 (-100.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 26,000 | 43,160 | 26,000 | 0 to 26 K |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 5.50 | 30,000 | 165,000 | 0 | 30 K to 0 (-100.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 5.25 | 20,000 | 105,000 | 30,000 | 50 K to 30 K (-40.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 4.90 | 20,000 | 98,000 | 50,000 | 70 K to 50 K (-28.57 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 70,000 | 116,200 | 70,000 | 0 to 70 K |
| Jan 26 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 2.58 | 350,000 | 903,000 | 350,000 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 1.70 | 450,000 | 765,000 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.94 | 107,000 | 314,580 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.94 | 45,000 | 132,300 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 6.74 | 50,000 | 337,000 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.83 | 175,000 | 495,250 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.83 | 125,000 | 353,750 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 1.66 | 952,000 | 1,580,320 | 952,000 | |
| Jun 14 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 1.69 | 450,000 | 760,500 | 450,000 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 2.94 | 107,000 | 314,580 | 107,000 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 9.31 | 107,000 | 996,170 | 0 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 5.89 | 45,000 | 265,050 | 0 | |
| Jan 20 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 9.31 | 107,000 | 996,170 | 107,000 | |
| Sep 22 2010 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 5.89 | 45,000 | 265,050 | 45,000 | |
| Sep 02 2010 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 2.83 | 125,000 | 353,750 | 125,000 | |
| Jan 26 2010 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 6.74 | 50,000 | 337,000 | 50,000 |
Page: 1